Success Metrics

Clinical Success Rate
89.5%

Based on 17 completed trials

Completion Rate
89%(17/19)
Active Trials
0(0%)
Results Posted
18%(3 trials)
Terminated
2(8%)

Phase Distribution

Ph not_applicable
11
42%
Ph phase_2
3
12%
Ph phase_3
3
12%

Phase Distribution

0

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
3(17.6%)
Phase 3Large-scale testing
3(17.6%)
N/ANon-phased studies
11(64.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

73.9%

17 of 23 finished

Non-Completion Rate

26.1%

6 ended early

Currently Active

0

trials recruiting

Total Trials

26

all time

Status Distribution
Completed(17)
Terminated(6)
Other(3)

Detailed Status

Completed17
Withdrawn4
unknown3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
26
Active
0
Success Rate
89.5%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (17.6%)
Phase 33 (17.6%)
N/A11 (64.7%)

Trials by Status

completed1765%
withdrawn415%
terminated28%
unknown312%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT00819208Not Applicable

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Completed
NCT00809575

Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes

Unknown
NCT01019187Phase 2

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Completed
NCT00003685Phase 3

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Completed
NCT00244894Not Applicable

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

Terminated
NCT00801346

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Completed
NCT00037024Not Applicable

Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer

Completed
NCT00416624Phase 2

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Completed
NCT00268502

Quality of Life in African-American or Caucasian Female Breast Cancer Survivors

Completed
NCT00662103Not Applicable

Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors

Completed
NCT00909662

Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers

Terminated
NCT00336102

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Completed
NCT00616590

Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer

Withdrawn
NCT00336089Not Applicable

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

Unknown
NCT00903305Not Applicable

Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Withdrawn
NCT00914043

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Withdrawn
NCT00460200

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

Withdrawn
NCT00574145Not Applicable

Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer

Completed
NCT00343616Phase 3

Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

Completed
NCT00799461Phase 3

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
26